State of the Art and Future Perspectives in Oncologic Imaging

Dear Colleagues,

Imaging has a fundamental role in oncology. Staging studies are indispensable for selecting a therapy or making a prognosis. Hardly any tumor surgery or radiotherapy is performed without prior image-guided planning. Likewise, we depend heavily on imaging to assess response to therapy. However, in contrast to its long-standing tradition in oncology, imaging is also one of the most exciting and dynamic fields: due to the constant relevance of imaging in the course of the disease, imaging is an omnipresent companion that mirrors the rapid and groundbreaking developments in the field of oncology. On the other hand, developments in the field of oncologic imaging are a genuine contributor to advances in the treatment of cancer patients. Thus, response criteria are based on imaging and are constantly refined, new theranostic targets can be addressed with the advances in imaging (e.g., using hybrid imaging techniques such as PET/CT or PET/MRI), and artificial intelligence imaging methods broaden the horizon even more.

The scope of this Special Issue is to reflect the double role of oncologic imaging as an established indispensable tool in clinical routine on the one hand, and as a thriving innovator pushing boundaries on the other. Therefore, we encourage the submission of articles both on state-of-the-art and future perspectives of oncologic imaging, including but not restricted to clinical and preclinical imaging studies and comprehensive reviews.

Kind regards,

Dr. Adrien Holzgreve
Dr. Lena M. Unterrainer
Prof. Dr. Wolfgang Kunz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.